PerkinElmer Integrates Electronic Laboratory Notebook (ELN) with Elsevier’s Reaxys® Chemistry Workflow Solution
Article Sep 20, 2012
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, has announced that its electronic laboratory notebook (ELN) can now be seamlessly integrated with Elsevier’s Reaxys®, a web-based workflow solution designed for chemistry researchers in drug discovery, chemicals and academic research.
“As chemists are increasingly turning to electronic laboratory notebooks to plan, execute and record their experiments, they also need ready access to complementary tools and data sources directly within the ELN interface.” said Michael Stapleton, general manager, PerkinElmer Informatics, “The interoperability of our ELN and Elsevier’s Reaxys provides researchers with access to extensive information on chemical compounds and related physical and pharmacological properties so that they can make better decisions. This integration also allows researchers to save valuable time by providing the ability to rapidly search and import external data while eliminating transcription errors.”
Capturing Reaxys content through PerkinElmer’s ELN gives researchers the power to simultaneously leverage information from both sources in order to make critical decisions throughout the chemistry research workflow. Chemical searches in Reaxys can be initiated in an experimental section in the ELN, based on existing or newly drawn compounds or reactions, and results are immediately available. Once suitable reactions are located and selected in Reaxys, they can be exported directly to the ELN and inserted into a pre-designed experiment, complete with reaction scheme, stoichimetry table and preparation text.
PerkinElmer and Elsevier will host an informative workshop at the American Chemical Society in Philadelphia, PA on August 20th at 8:30 am EST to demonstrate and discuss the benefits of integrating Reaxys and PerkinElmer’s ELN. To register for the workshop, signup here.
Integrating the ELN with Reaxys is available at no extra charge to customers who already have both systems.
Untargeted metabolomics approaches are allowing previously unreported insights into the pathogenesis of disease. However, identifying the large numbers of unknown and structurally diverse metabolites typically present in biological samples has proven to be a major bottleneck. Fortunately, recent advances in technology and software are helping to overcome this challenge.READ MORE
The UK’s national health system needs to take a hard look at their priorities and procedures to ensure that rapid advances in molecular diagnostics in lung cancer are translated into a practical service for all patients, according to a report launched at the British Thoracic Oncology Group Annual Conference.READ MORE
First developed in the 1970s, recent developments are making microflow liquid chromatography techniques more robust – enticing researchers to revisit the opportunities it offers for more sensitive, high-throughput analyses requiring smaller sample volumes than standard flow techniques.READ MORE